The defective signaling through the ATM-Chk2 pathway and the failure of MDC1 and Nbs1 to form discrete foci in response to TMZ in the resistant GBM cells suggest that these cells exhibit defective cell cycle checkpoints. The gene discussed is CHEK2; the disease is glioblastoma.